摘要
目的:探讨 α-细辛脑注射液佐治小儿喘息性肺疾患的疗效及安全性。方法 :选择在我科住院确诊为毛细支气管炎、支气管哮喘合并肺部感染及伴有喘息的支气管肺炎患儿共 10 0例 ,随机分为治疗组和对照组 (各 5 0例 ) ,两组均给予常规抗感染、补液对症治疗 ,对照组 72 h内不加任何支气管扩张剂 (哮喘急性发作者除外 ) ;治疗组加用α-细辛脑注射液静点 ,疗程 5～ 7d;分别观察两组患儿的临床症状、体征持续时间 ,以确定治疗效果。结果:治疗组咳嗽、咳痰、气喘、肺部罗音等临床症状和体征均较对照组缓解快 ,持续时间短 (P <0 .0 5 )。治疗组总有效率为 83.33% ,对照组总有效率为 5 2 .0 7% (P <0 .0 1)。治疗过程中未见明显不良反应。结论:α-细辛脑注射液佐治小儿喘息性肺疾患疗效满意且安全可靠 ,值得在临床中推广使用。
Objective: To investigate the efficacy of α asarone injection as add on treatment and side effect of pulmonary disease with wheeze on children. Methods: 100 hospital cases, who were diagnosed bronchiolitis, asthma with pulmonary infection and pneumonia with wheeze respectively, were randomly divided into two groups, The control group were received regular treatment; The treated group were received α asarone injection on above base. Results: After 7 days' therapy, the rate of efficacy in treated group was 83.33% and 52.07%,in the control one (P<0.01) cough, productive, wheeze and rales all disappeared more rapidly in treated group than control one (P<0.05).Conclusion: α asarone injection, as add on treatment of pulmonary disease with wheeze, has a good efficacy and no serious side effects.
出处
《新疆医科大学学报》
CAS
2004年第2期161-162,共2页
Journal of Xinjiang Medical University
